STOCK TITAN

Elanco Animal Health Incorporated - ELAN STOCK NEWS

Welcome to our dedicated page for Elanco Animal Health Incorporated news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health Incorporated stock.

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health, committed to innovating and delivering products and services to improve the health and wellness of both farm animals and pets. Established with nearly 70 years of heritage, Elanco operates in over 90 countries with a diverse portfolio of approximately 200 brands. Their core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue through three primary avenues:

  • Enhancing food security by improving the health and productivity of farm animals, thereby contributing to a safer, more affordable, and abundant food supply.
  • Helping pets live longer, healthier lives through advanced veterinary products.
  • Improving food safety standards globally.

Elanco’s dedication to animal health is reflected in their continuous innovation and quality systems, driven by a shared vision of enhancing life for animals and humans alike. This commitment is evident in their recent achievements and ongoing projects. For instance, Elanco's collaboration with Agtech company, Cattler, aims to provide data-driven solutions to cattle farmers, enhancing operational efficiency and productivity through services like Benchmark™ and Experior™.

Elanco's financial health is strong, with the company reporting consistent revenue growth and strategic investments aimed at future expansion. In their recent financial results, Elanco posted a 5% growth in the fourth quarter and strengthened their commercial infrastructure to support ongoing and future growth. They also announced the divestiture of their aqua business to streamline operations and focus on core areas, which is expected to reduce their debt leverage significantly by year-end.

Environmental sustainability is another critical focus for Elanco. Their recent partnership with Athian to create a livestock carbon insetting marketplace is a significant step towards reducing greenhouse gas emissions in the dairy and beef industries. Products like Bovaer®, which significantly reduce methane emissions from cattle, exemplify Elanco's commitment to sustainable farming practices.

Overall, Elanco continues to be at the forefront of animal health innovation, with substantial investments in R&D, strategic partnerships, and a clear commitment to sustainability and community health.

Rhea-AI Summary

Elanco Animal Health has announced the FDA's completion of a multi-year review of Bovaer, a methane-reducing feed ingredient for dairy cattle, confirming its safety and efficacy. Bovaer can reduce methane emissions by about 30%, creating new revenue streams for dairy farmers through carbon credits. Elanco has also expanded its agreement with dsm-firmenich to distribute Bovaer across North America, including Canada and Mexico. This innovation aims to support climate-neutral dairy farming and meet the increasing demand for sustainable products. Bovaer is expected to generate significant value for farmers and the environment, potentially addressing global warming concerns through reduced greenhouse gas emissions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
-
Rhea-AI Summary

Elanco Animal Health (NYSE: ELAN) announced its participation in the Stifel 2024 Jaws and Paws Conference, scheduled for May 29, 2024. Todd Young, Elanco's Executive Vice President and CFO, will engage in a fireside chat at 8:00 a.m. ET. Interested parties can access a live audio webcast through the 'Events and Presentations' section of Elanco's investor website. Additionally, a replay of the webcast will be available for 30 days post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
conferences
-
Rhea-AI Summary

Elanco Animal Health reported revenue of $1,205 million and net income of $32 million in the first quarter of 2024. Adjusted EBITDA was $294 million, with adjusted EPS of $0.34. The company updated its full-year 2024 financial guidance, expecting revenue of $4,460 to $4,515 million and adjusted EPS of $0.88 to $0.96.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.93%
Tags
Rhea-AI Summary
Elanco Animal Health launches 'Parvo is Poop' campaign to raise awareness on National Parvo Awareness Day. The campaign aims to save 1 million puppies by 2030 by educating the public about the devastating parvovirus affecting over 330,000 puppies annually, with a 91% fatality rate if untreated. Elanco introduces a tracking site for parvovirus outbreaks and highlights symptoms and treatment solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.1%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) has confirmed the date for its first quarter 2024 financial results announcement and conference call. The announcement will take place on May 8, 2024, with a conference call scheduled for 8:00 a.m. eastern time on the same day. Investors, media, and the general public can access a live webcast of the call on Elanco's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
-
Rhea-AI Summary
Elanco Animal Health Incorporated appoints two new independent directors, Kathy Turner and Craig Wallace, expanding the Board to 14 members. The Board's Finance, Strategy and Oversight Committee is renamed. Elanco reaches a cooperation agreement with Ancora Holdings Group
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
management
Rhea-AI Summary
Elanco Animal Health CEO, Jeff Simmons, discusses the company's commitment to sustainability by reducing cattle emissions, particularly methane, on Mad Money with Jim Cramer. Elanco aims to pioneer solutions for farmers that can create new value and climate-neutral farms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.11%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health appoints Shiv O'Neill as Executive Vice President, General Counsel, and Corporate Secretary, bringing over 20 years of legal expertise to lead the company's legal team and support growth objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
management
-
Rhea-AI Summary
Elanco Animal Health Incorporated (ELAN) responds to Ancora Holdings Group, LLC's nomination of director candidates despite Elanco's operational progress and engagement efforts. Elanco's CEO Jeff Simmons leads the successful execution of the Innovation, Portfolio, and Productivity strategy, resulting in growth and a promising pipeline. Shareholders have seen a 39% stock increase in the past year, surpassing industry peers. While Elanco welcomes shareholder engagement, Ancora's demands for Board changes are met with resistance. Elanco has made strategic moves to improve performance, including divesting the aqua business and enhancing corporate governance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) reported fourth quarter and full year 2023 financial results, with revenue of $1,035 million and $4,417 million respectively. The company announced a strategic restructuring impacting approximately 420 personnel to generate savings and reinvest in value creation opportunities. Full year 2024 guidance includes revenue of $4,450 to $4,540 million and adjusted EBITDA of $960 to $1,010 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags

FAQ

What is the current stock price of Elanco Animal Health Incorporated (ELAN)?

The current stock price of Elanco Animal Health Incorporated (ELAN) is $11.86 as of December 23, 2024.

What is the market cap of Elanco Animal Health Incorporated (ELAN)?

The market cap of Elanco Animal Health Incorporated (ELAN) is approximately 5.8B.

What is Elanco Animal Health's core mission?

Elanco's core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue by enhancing food security, improving pet health, and elevating food safety standards globally.

In how many countries does Elanco operate?

Elanco operates in over 90 countries worldwide.

What recent collaborations has Elanco engaged in?

Elanco recently collaborated with Agtech company Cattler to provide data-driven solutions to cattle farmers through services like Benchmark™ and Experior™.

What is the significance of Elanco's partnership with Athian?

The partnership with Athian aims to create a livestock carbon insetting marketplace, reducing greenhouse gas emissions and promoting sustainable farming practices.

What are some of Elanco's notable products?

Elanco's notable products include Seresto®, Experior™, and Bovaer®, the latter being a methane-reducing feed ingredient for cattle.

How is Elanco addressing sustainability in animal farming?

Elanco addresses sustainability through innovative products like Bovaer®, which reduces methane emissions from cattle, and partnerships aimed at creating carbon insetting marketplaces.

What financial goals has Elanco set for 2024?

Elanco expects constant currency revenue growth of 2% to 3% for 2024, driven by new product launches and operational improvements. They also anticipate significant debt reduction through strategic divestitures.

How does Elanco contribute to food safety?

Elanco contributes to food safety by developing products that improve the health and performance of farm animals, thereby ensuring a safer and more reliable food supply.

What is Elanco's approach to innovation?

Elanco's approach to innovation involves continuous R&D investments, strategic partnerships, and the development of new products that address pressing issues in animal health and sustainability.

How does Elanco support the health and wellness of pets?

Elanco supports pet health through an extensive range of veterinary products designed to improve the quality and longevity of pets' lives.

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Stock Data

5.80B
490.44M
0.71%
98.94%
3.07%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD